167 related articles for article (PubMed ID: 22882510)
1. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.
de Almeida-Neto C; Sabino EC; Liu J; Blatyta PF; Mendrone-Junior A; Salles NA; Leão SC; Wright DJ; Basques FV; Ferreira JE; Busch MP; Murphy EL;
Transfusion; 2013 Apr; 53(4):827-34. PubMed ID: 22882510
[TBL] [Abstract][Full Text] [Related]
2. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
[TBL] [Abstract][Full Text] [Related]
3. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Kusendová K; Gavorník P; Sabaka P; Sviteková K
Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
[TBL] [Abstract][Full Text] [Related]
4. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
[TBL] [Abstract][Full Text] [Related]
5. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
6. Safety of blood supply in the Caribbean countries: role of screening blood donors for markers of hepatitis B and C viruses.
Cruz JR; Pérez-Rosales MD; Zicker F; Schmunis GA
J Clin Virol; 2005 Dec; 34 Suppl 2():S75-80. PubMed ID: 16461244
[TBL] [Abstract][Full Text] [Related]
7. Payment for whole blood donations in Lithuania: the risk for infectious disease markers.
Kalibatas V
Vox Sang; 2008 Apr; 94(3):209-215. PubMed ID: 18069929
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015).
Fiedler SA; Oberle D; Chudy M; Scheiblauer H; Henseler O; Halbauer J; Heiden M; Funk M
Vox Sang; 2019 Jul; 114(5):443-450. PubMed ID: 31012114
[TBL] [Abstract][Full Text] [Related]
9. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.
Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H;
Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005.
Andrade AF; Oliveira-Silva M; Silva SG; Motta IJ; Bonvicino CR
Mem Inst Oswaldo Cruz; 2006 Sep; 101(6):673-6. PubMed ID: 17072482
[TBL] [Abstract][Full Text] [Related]
11. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
Bruhn R; Lelie N; Busch M; Kleinman S;
Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
[TBL] [Abstract][Full Text] [Related]
12. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany.
Houareau C; Offergeld R
Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for hepatitis B and C in multi-transfused patients in Uruguay.
López L; López P; Arago A; Rodríguez I; López J; Lima E; Insagaray J; Bentancor N
J Clin Virol; 2005 Dec; 34 Suppl 2():S69-74. PubMed ID: 16461243
[TBL] [Abstract][Full Text] [Related]
14. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
15. Performance of the serologic and molecular screening of blood donations for the hepatitis B and C viruses in a Mexican Transfusion Center.
Chiquete E; Sánchez LV; Becerra G; Quintero A; Maldonado M; Panduro A
Ann Hepatol; 2005; 4(4):275-8. PubMed ID: 16432494
[TBL] [Abstract][Full Text] [Related]
16. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors.
Seo DH; Whang DH; Song EY; Kim HS; Park Q
Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors.
Flichman DM; Blejer JL; Livellara BI; Re VE; Bartoli S; Bustos JA; Ansola CP; Hidalgo S; Cerda ME; Levin AE; Huenul A; Riboldi V; Treviño EM; Salamone HJ; Nuñez FA; Fernández RJ; Reybaud JF; Campos RH
BMC Infect Dis; 2014 Apr; 14():218. PubMed ID: 24755089
[TBL] [Abstract][Full Text] [Related]
19. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
20. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.
Whyte GS; Savoia HF
Med J Aust; 1997 Jun; 166(11):584-6. PubMed ID: 9201178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
